2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 321

Effects of Bariatric Surgery on Long-Term Quality of Life Outcomes for Obese Patients with Osteoarthritis
Abstract Number: 322

Reduction of Treatment Needed for Knee Osteoarthritis after Bariatric Surgery
Abstract Number: 323

Perioperative Interventions for Smoking Cessation in Hip and Knee Arthroplasty for Osteoarthritis and Other Non-Traumatic Diseases
Abstract Number: 324

Activity Limitations in Persons with Low, Medium, and High Levels of Pain Prior to Total Knee Replacement: Implications for Appropriateness and Efficacy
Abstract Number: 325

Best Performing Definition of Accelerated Knee Osteoarthritis
Abstract Number: 326

Older Adults without Extreme Obesity Are at Highest Risk for Accelerated Knee Osteoarthritis
Abstract Number: 327

The Relation of Plasma Vitamin K Status to Meniscal Pathology in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 328

Associations Between Body Composition Measures of Obesity and Radiographic Osteoarthritis in Older Adults: Data from the Dong-Gu Study
Abstract Number: 329

Serum Leptin and Risk of Knee Pain and Osteoarthritis: Multicenter Osteoarthritis Study
Abstract Number: 330

Calf Muscle Adiposity Is Associated with Impaired Physical Performance in Knee OA
Abstract Number: 331

Are Metabolic Factors Associated with Shoulder Osteoarthritis? a Multicentric Study.
Abstract Number: 332

Adipokine SERUM Levels in Patients with EARLY Knee Osteoarthritis with and without Metabolic Syndrome
Abstract Number: 333

Smoking and Knee and Hip Osteoarthritis Evolution. Results from the Knee and Hip Osteoarthritis Long-Terme Assessment Cohort
Abstract Number: 334

Lifetime Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project
Abstract Number: 335

Prevalence of Hand Osteoarthritis and Factors Associated with Pain in Korean Farmers

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].